Implementation of Bedaquiline, Pretomanid, and Linezolid in the United States: Experience Using a Novel All-Oral Treatment Regimen for Treatment of Rifampin-Resistant or Rifampin-Intolerant Tuberculosis Disease Free

• Abstracts

Reply to van Deun and Decroo Free

• Extract

Aminoglycosides and Capreomycin in the Treatment of Multidrug-resistant Tuberculosis: Individual Patient Data Meta-analysis of 12 030 Patients From 25 Countries, 2009–2016 Free

• Abstract

Tuberculosis Healthcare Workers: There Goes My Hero Free

• Extract

Factors Associated With All-Cause Mortality Among Patients With Multidrug-Resistant Tuberculosis—United States, 1993–2013 Free

• Abstract
• Supplementary data

Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance Free

• Abstract
• Supplementary data

Reply to Soman et al, Alffenaar et al, Metcalfe et al, and Raoult Get access

• Extract

Extensive Drug Resistance Acquired During Treatment of Multidrug-Resistant Tuberculosis Get access

• Abstract
• Supplementary data

Mortality Among Tuberculosis Patients With Acquired Resistance to Second-line Antituberculosis Drugs—United States, 1993–2008 Get access

• Abstracts

Epidemiology of Pyrazinamide-Resistant Tuberculosis in the United States, 1999–2009 Get access

• Abstract
• Supplementary data

Acquired Resistance to Second-Line Drugs Among Persons With Tuberculosis in the United States Get access

• Abstract

Extensively Drug-Resistant Tuberculosis: “There must be some kind of way out of here” Get access

• Abstract

Cryptosporidium, Enterocytozoon, and Cyclospora Infections in Pediatric and Adult Patients with Diarrhea in Tanzania Get access

• Abstract

Central Nervous System Infections with Nontuberculous Mycobacteria Get access